Ardelyx reported $-19080000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Abbott USD 1.78B 454M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Ardelyx USD -19080000 23.72M Jun/2025
Corcept Therapeutics USD 35.15M 14.6M Jun/2025
Life Technologies USD -19530000 4.56M Jun/2025
Sanofi EUR 3.94B 3.44B Jun/2025
TG Therapeutics USD 28.19M 23.13M Jun/2025
United Therapeutics USD 309.5M 12.7M Jun/2025